Key facts
- It has raised $17.6M; the latest was Later Stage VC ($5.3M) in Jan 2025.
- Notable investors include Korea Investment Partners, Smilegate Investment, DAYLI Partners, BiiG WAVE, Alpen Route Asset Management — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Dr.Diary
- ·The full record, as it builds
Funding rounds
No funding rounds for Dr.Diary are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dr.Diary
Developer of a diabetes management platform designed to help patients manage and record their blood glucose levels. The company's platform consists of communication tools and personal consultation services with healthcare professionals and helps patients record their daily exercise routines and food supplements, enabling users to be provided with insights on foods to manage glucose levels.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2017
- Employees
- 43
- Website
- drdiary.co.kr/
- Ownership
- Privately Held (backing)
Dr.Diary doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dr.Diary shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dr.Diary in its N-PORT filings yet. We sweep new filings monthly.